A new treatment for a debilitating genetic disease causing sudden sight loss is now available on the NHS in England. Evidence suggests that the drug, idebenone, may improve eyesight and boost the ...
NurExone (OTC:NRXBF) is developing a product known as ExoPTEN that is designed to treat patients with acute spinal cord injuries, while also conducting preclinical tests for other conditions that ...
MENLO PARK, Calif., Dec. 19, 2024 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences,” or the “Company”), an eyecare technology company focused on developing and commercializing ...
MENLO PARK, Calif., Sept. 09, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and commercializing ...
Residents of Orile-Agege community in Lagos State have received free eye screening, treatment, and cataract surgeries in commemoration of 2025 World Sight Day. The outreach was organised by Lions ...
Sight Sciences, Inc. ((SGHT)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst ...